John Macaskill is listed as a director on 10 SEC Form D filings by 1 issuer between Mar 2012 and May 2018: Provista Diagnostics Inc. (Scottsdale, AZ — biotechnology — 2012–2018; $7.49M reported sold to 35 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Jack Levine (10 shared filings), Jeffrey Gilman (10 shared filings), John Zicarelli (10 shared filings), Robert Hariri (10 shared filings), Anne Busquet (9 shared filings) and 9 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 10 public filings for John Macaskill and found 7 differences: Form D filed 51 days after the first sale; Form D filed 27 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.